toyocamycin has been researched along with Lung Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kang, J; Lee, CH; Lee, DK | 1 |
1 other study(ies) available for toyocamycin and Lung Neoplasms
| Article | Year |
|---|---|
Cell cycle arrest and cytochrome c-mediated apoptotic induction in human lung cancer A549 cells by MCS-C2, an analogue of sangivamycin.
Topics: Apoptosis; Cell Cycle; Cell Line, Tumor; Cytochromes c; Humans; Lung Neoplasms; Pyrimidine Nucleosides; Toyocamycin | 2010 |